| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), ABSI's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 8.63M | $87.70M | - | |
| CFO | 484.9K | $4.93M | - | |
| Other | 421.4K | $965.1K | - | |
| Dir | 242.4K | - | - | |
| VP | 199.1K | $2.02M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Szela Mary T47 | Director | Buy | 12,900 | $11.54 | $148,866.00 | +153.6% | -18.1% | - | |
| May 13, 2026 | Pangalos Menelas N | Director | Buy | 37,453 | $5.36 | $200,748.08 | +19.2% | +77.5% | - | |
| Mar 12, 2026 | Busch Andreas | Chief Innovation Officer | Buy | 100,000 | $2.29 | $229,000.00 | +31.1% | +177.4% | - | |
| Feb 27, 2026 | Pangalos Menelas N | Director | Buy | 75,095 | $2.74 | $205,760.30 | +65.9% | +121.9% | - | |
| Feb 2, 2026 | McClain Sean | Chief Executive Officer | Sell | 26,761 | $2.99 | $80,015.39 | -0.3% | +86.1% | - | |
| Feb 2, 2026 | Jonasson Zachariah | CFO / Cbo | Sell | 17,496 | $2.99 | $52,313.04 | -4.4% | +86.1% | - | |
| Dec 5, 2025 | Van Houten Frans | Director | Buy | 40,000 | $3.72 | $148,800.00 | +171.5% | -27.9% | - | |
| Sep 22, 2025 | Pangalos Menelas N | Director | Buy | 95,785 | $2.66 | $254,788.10 | +527.0% | +36.4% | +298.1% | |
| Sep 22, 2025 | Bedrick Todd | SVP, CAO | Buy | 10,000 | $2.70 | $27,000.00 | +5.9% | +36.4% | +298.1% | |
| Jul 28, 2025 | Busch Andreas | Chief Innovation Officer | Buy | 50,000 | $3.04 | $152,000.00 | +18.0% | +51.5% | +154.5% |